Monitor for imminent takedown of shares under this shelf; any offering will be highly dilutive given current market cap. Downward pressure on share price is likely upon announcement of any issuance.
Price Chart
Executive Summary
InMed Pharmaceuticals' S-3 shelf registration has become effective, allowing the company to raise up to $50 million through future offerings of common shares, preferred shares, warrants, or other securities. Given the company's $2 million market cap and existing going concern doubts, this creates a significant dilution overhang.
Key Facts
- S-3 shelf registration became effective on March 30, 2026
- Company may raise up to $50 million in aggregate value over time
- Offering can include common stock, preferred stock, warrants, subscription rights, or units
- Market cap is only $2 million, implying potential for extreme dilution
- Company faces substantial doubt about going concern due to operating losses and adverse U.S. legislation impacting BayMedica
Financial Impact
Up to $50 million in potential dilution against a $2 million market cap
Risk Factors
- Extreme shareholder dilution due to large shelf size relative to market cap
- Equity issuances could further depress share price in a low-liquidity environment
- Ongoing going concern risks exacerbated by reliance on capital markets for survival
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-000999 |
| Document: 9999999995-26-000999-index.html | 9999999995-26-000999 |
| Document: 9999999995-26-000999.txt | 9999999995-26-000999 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 22d ago | 425 | $1.31 $1.39 | ▲ +6.11% | ▲ +6.61% | $1.33 (+1.53%) |
Jul 10, 2026 12w ago | 8-K | $1.57 $1.52 | ▲ +3.18% | ▲ +2.40% | $1.33 (+15.29%) |
Jul 2, 2026 13w ago | S-4 | $1.56 $1.66 | ▼ −6.41% | ▼ −5.48% | $1.33 (+14.74%) |
Jun 11, 2026 16w ago | Insider Cluster | $1.58 $1.49 | ▼ −5.70% | ▼ −6.13% | $1.33 (−15.82%) |
Jun 10, 2026 16w ago | 8-K | $1.51 $1.48 | ▼ −1.99% | ▼ −5.42% | $1.33 (−11.92%) |
May 19, 2026 19w ago | 425 | $1.60 $1.69 | ▲ +5.63% | ▲ +3.38% | $1.33 (−16.87%) |
May 19, 2026 19w ago | 8-K | $1.60 $1.69 | ▲ +5.63% | ▲ +3.38% | $1.33 (−16.87%) |
May 19, 2026 19w ago | 8-K | $1.60 $1.66 | ▼ −3.75% | ▼ −1.45% | $1.33 (+16.87%) |
Apr 27, 2026 22w ago | 8-K | $0.7010 $0.7480 | ▼ −6.70% | ▼ −5.01% | $1.33 (−89.73%) |
Apr 3, 2026 26w ago | 8-K | $0.6950 $0.7130 | ▲ +2.59% | ▼ −1.54% | $1.33 (+91.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access